聚利寶控股(08527.HK)已就撤銷有關索償向法院提出申請
格隆匯11月1日丨聚利寶控股(08527.HK)公吿,董事會得悉最近公司股份於聯交所的成交價格及成交量的波動。經作出有關公司於相關情況下合理查詢後,董事會確認,除公吿下文披露的資料外,其並不知悉有關導致股份成交價格或成交量的波動任何原因,或任何必須公佈以避免本公司證券出現虛假市場的資料,或任何根據香港法例第571章證券及期貨條例第XIVA部須予披露內幕消息。
公司已就撤銷有關索償向新加坡最高法院("新加坡法院")提出申請,新加坡法院經審議該案後,斷定應給予機會就有關索償進行詳細爭辯,故此須進行審訊。聆訊日期待定。公司將於必要時另行刊發公吿,以就有關索償的進展提供最新資訊。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.